DBV Technologies (DBVT) Goodwill & Intangibles (2015 - 2026)
DBV Technologies (DBVT) posted quarterly Goodwill & Intangibles of $100000.0 for Q1 2026, up 244.83% year-on-year from $29000.0 in Q1 2025, and up 376.19% on a QoQ basis from $21000.0 in Q3 2025.
DBV Technologies (DBVT) Goodwill & Intangibles (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has reported Goodwill & Intangibles for 12 consecutive years, with $100000.0 the latest figure, recorded in Q1 2026.
- Quarterly Goodwill & Intangibles rose 244.83% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100000.0 (up 244.83% YoY) and the FY2024 annual result came in at $40000.0, down 31.03% from the prior year.
- Goodwill & Intangibles climbed to $100000.0 in Q1 2026 per DBVT's latest filing, from $21000.0 in the prior quarter.
- Over the last five years, Goodwill & Intangibles for DBVT reached as high as $100000.0 in Q1 2026 and fell as low as $10000.0 in Q4 2022.
- A 5-year average of $37937.5 and a median of $34500.0 in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles sank 57.69% — and 2023, when it surged 480.0%.
- Year by year, Goodwill & Intangibles stood at $10000.0 in 2022, then jumped by 480.0% to $58000.0 in 2023, then slumped by 31.03% to $40000.0 in 2024, then plunged by 47.5% to $21000.0 in 2025, then soared by 376.19% to $100000.0 in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $100000.0, $21000.0, and $26000.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Sep 30, 2025 | 21,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 46,000.00 |
| Mar 31, 2024 | 52,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 14,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 26,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 32,000.00 |